Published in
Springer Nature [academic journals on nature.com], Leukemia, 11(31), p. 2398-2406, 2017
DOI: 10.1038/leu.2017.253
Links
Tools
Assessment of imatinib as first-line treatment of chronic myeloid leukemia: 10-year survival results of the randomized CML study IV and impact of non-CML determinants
Journal article published in 2017 by
M. de Wit,
B. Schlegelberger,
A. Voskanyan,
W. Seifarth,
B. Spieß,
F. Stegelmann,
C. F. Waller 
,
K. Spiekermann,
M. Wernli,
F. Schlegel,
R. Schlag,
L. Trümper,
J. Thomalla,
C. Scheid,
P. Schafhausen
and other authors.
,
K. Spiekermann,
M. Wernli,
F. Schlegel,
R. Schlag,
L. Trümper,
J. Thomalla,
C. Scheid,
P. Schafhausen
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 